BACHEM N revenue breakdown overview

BACHEM N revenue for the last year amounted to 605.26 M CHF, the most of which — 327.00 M CHF — came from its highest performing source at the moment, Commercial Active Pharmaceutical Ingredients, the year earlier bringing 309.03 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought BACHEM N 183.80 M CHF.